Systemic sclerosis & Raynaud's

The differential crosstalk of the skin–gut microbiome axis as a new emerging actor in systemic sclerosis

Rheumatology (Oxford)Published Cross-sectional study

Authors' conclusion

Different microbiota signatures and FFA profiles were found for the two groups of patients. Despite being in different body districts, the cutaneous Sphingobacteria and faecal Lentisphaerae appear interdependent.

Study context

Population
SSc patients with ACA or anti-Scl70 autoantibodies
Participants
25 patients
Exposure
ACA+ vs anti-Scl70+ SSc patients
Outcome
Skin, oral and gut microbiota and serum and faecal FFA profiles
Methodological detailsnext-generation sequencing, GC-MS
  • Next-generation sequencing
  • GC-MS

Main finding

As reported in the abstract

Correlation of cutaneous Sphingobacteria and faecal Lentisphaerae
rho = 0.42; P = 0.03
Faecal medium-chain free fatty acid (FFAs) significantly higher in ACA+ vs anti-Scl70+
P < 0.05
Faecal hexanoic acids significantly higher in ACA+ vs anti-Scl70+
P < 0.001

Observational data: associations, not effects.

Original publication

The differential crosstalk of the skin–gut microbiome axis as a new emerging actor in systemic sclerosis. Rheumatology (Oxford). Published 8 May 2023. doi:10.1093/rheumatology/kead208

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.